|
|
|
|||||
|
|
||||||
|
Computerized results of Menopause Type® Questionnaire: |
||||||
|
Menopause Type® Seven |
||||||
|
Menopause
Type® Seven has symptoms that reveal decreased
progesterone function with adequate
estradiol and testosterone function. Health risks associated with Menopause Type® Seven may include osteoporosis, high blood pressure and
anxiety disorders. Because progesterone function is suboptimal, it may not
properly oppose the actions of estrogens or of androgens such as
testosterone. This may result in some mild androgen or estrogens excess
symptoms. Once progesterone is supported to normal function, any minor
androgen or estrogen excess symptoms and risks are usually corrected. |
See Pages
127-133 |
|||||
|
PROTOCOL: The following protocol provides women with
Menopause Type® 7 information on which nutritional and herbal formulations
can support the normal function of hormone responsive tissues. Please review the Advanced Integrative Management of
Menopause document for more detailed information. |
||||||
|
Foundational Interventions: |
||||||
|
Foundational interventions include lifestyle and dietary choices that support optimal hormone function. In addition, a high grade multiple vitamin mineral formulation rich in antioxidants and essential fatty acids rich in docosahexaenoic acid are required for optimal hormone function. |
||||||
|
||||||
|
||||||
|
Primary Endocrine Formulations : |
||||||
|
Primary Endocrine Nutraceutical formulations should be used to support the function of hormone producing glands and hormone responsive tissues. The primary formulations that are appropriate to manage hormonal imbalances observed in Menopause Type® Seven include: |
||||||
|
Progesto-Mend™ is a unique blend of phytoprogesterones, adaptogens and other herbs to naturally support hormonal balance by supporting the ideal function of progesterone producing tissues and of progesterone responsive tissues as needed in Menopause Type® Seven. More Information on Progesto-Mend™ |
||||||
|
Please Find a Healthcare Professional in your area to customize these protocols. |
||||||
|
Secondary Endocrine Formulations: |
||||||
|
Since decreased thyroid
function can adversely affect the function of other hormones, a nutraceutical formulation to support the function
of the thyroid gland and the liver (which converts T4 to T3)
and also supports the function and response of tissues that respond to
thyroid hormones should be used if there are signs and symptoms of decreased thyroid function. As noted, there may be decreased blood glucose function in Menopause Type® Seven due to the primary hormone imbalances. Excessive body weight also increases the risk for decreased blood glucose function. A nutraceutical formulation to support healthy blood glucose function should be used if there are signs and symptoms of decreased blood sugar function |
||||||
|
Thyro-Mend™ is a synergistic combination of iodine containing seaweeds, and herbs which contain phytothyroidogenic, phyto-thyroid-receptor agonists, and other herbs designed to promote optimal function of thyroid hormones by maintaining the health of thyroid hormone producing tissues and by supporting the healthy function of tissues that respond to thyroid hormones. More information on Thyro-Mend™. |
||||||
|
Glucobrium
is a synergistic formulation of phytotherapeutic extracts which mimic and
potentiate the actions of insulin and support healthy blood glucose function.
More information on Glucobrium. |
||||||
|
When to Consider Hormone Precursors & Bioidentical Hormone Replacement Therapy |
||||||
|
A hormone precursor such as Pregnenolone 25 Mg Tab may be used to support
hormone production pathways that create progesterone. They have mild hormone
actions in and of themselves, and do not have the same risks that are
associated with Hormone Replacement Therapies (HRT). Bioidentical Hormone Replacement Therapy (BHRT), while considered more appropriate than synthetic hormone therapies, does not support the hormone production pathways, but instead provides “replacement”, which may further diminish endogenous hormone production. Evaluation of hormone levels, use of hormone precursors as needed, and as a final course of action, the prescription of bioidentical hormone therapies should be considered only when restoration of normal function is not possible. |
||||||
|
Also Review: |
||||||
|
Make the Right Choice |
||||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown
such commitment as to take an extensive course of study on menopause type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a Healthcare Professional . |
||||||
|
How Your
Menopause Type® Was Calculated (www.YourMenopauseType.com/Questionnaire.html#Calculate) |
||||||
|
|
||||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
||||||
|
Review Disclaimer & Legal (www.YourMenopauseType.com/Disclaimer) |
||||||
YourMenopauseType.com,
Inc.
|
||||||
|
Last
update 03/18/07 |
||||||
|
|
||||||